This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s […]
Biotechnology in Countries Beginning with “I” – Part 9: Iran Read Post »
TechTransferWatch is a search engine and alert service for licenseable technologies from academic labs, foundations, and government. Click the patents
This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s
TechTransferWatch is a search engine and alert service for licenseable technologies from academic labs, foundations, and government. Click the patents
This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s
Once in a Blue Moon: When BIO and DIA Worlds Collide #BIO2015 #DIA2015 Read Post »
This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Dyslipidaemia: Focus shifts from LDL-C to HDL-C
Go to paperABSTRACT: In this current analysis of the antidyslipidaemics market, a shift in focus from lo…
TechTransferWatch is a search engine and alert service for licenseable technologies from academic labs, foundations, and government. Click the patents
TechTransferWatch is a search engine and alert service for licenseable technologies from academic labs, foundations, and government. Click the patents
Cannabis, commonly known as marijuana, weed or pot, is a natural product derived from the Cannabis sativa plant. It has been used medicinally for thousands of years. Recent legislation allowing the use of medical marijuana in over 23 US states has spurred interest in developing pharmaceutical-derived Cannabis products to treat a variety of clinical indications ranging from pain relief to epilepsy. Many products are in late stage clinical development in the US and elsewhere. This article reviews the medicinal properties of Cannabis and describes pharmaceutical-derived Cannabis products that are currently being developed for theUS market.